Friday May 27, 2022
Result of Annual General Meeting and Strategy Update
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Result of Annual General Meeting and Strategy Update Brighton, United Kingdom – 27 May 2022 – Destiny Pharma plc (AIM: DEST), a […]
Thursday May 26, 2022
Destiny Pharma plc Board changes
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Destiny Pharma appoints three Non-Executive Directors Brighton, United Kingdom – 26 May 2022 – Destiny Pharma plc (AIM:DEST), a clinical stage innovative […]
Thursday May 12, 2022
Landmark NTCD-M3 data to be presented at Anaerobe
Destiny Pharma plc (“Destiny Pharma” or “the Company”) World leading C. difficile scientists to present landmark data on the ability of NTCD-M3 to colonise the gut after antibiotic administration Brighton, […]
Wednesday May 4, 2022